학술논문
A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART, SWOG S1609)
Document Type
Article
Author
Adams, S.; Othus, M.; Mayerson, E.; Plets, M.; Patel, S.P.; Kurzrock, R.; Miller, K.D.; Storniolo, A.M.V.; Chugh, R.; Schuetze, S.M.; Chamberlin, M.D.; Haley, B.J.; Reddy, M.P.; Anderson, S.A.; Zimmerman, C.T.; O’Dea, A.P.; Mirshahidi, H.R.; Ahnert, J.R.; Brescia, F.J.; Hahn, O.; Raymond, J.M.; Biggs, D.D.; Connolly, R.M.; Sharon, E.; Korde, L.A.; Gray, R.J.; Blanke, C.D.; Chae, Y.K.
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 15 January 2022, 28(2):271-278)
Subject
Language
English
ISSN
15573265
10780432
10780432